Literature DB >> 22550184

H5N1 influenza virus seroepidemiological studies: the facts revisited.

Michael T Osterholm, Nicholas S Kelley.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22550184      PMCID： PMC3361374          DOI： 10.1073/pnas.1203949109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  4 in total

1.  H5N1 influenza viruses: facts, not fear.

Authors:  Peter Palese; Taia T Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-25       Impact factor: 11.205

2.  Genotypic diversity of H5N1 highly pathogenic avian influenza viruses.

Authors:  Zi-Ming Zhao; Kennedy F Shortridge; Maricarmen Garcia; Yi Guan; Xiu-Feng Wan
Journal:  J Gen Virol       Date:  2008-09       Impact factor: 3.891

3.  Seroevidence for H5N1 influenza infections in humans: meta-analysis.

Authors:  Taia T Wang; Michael K Parides; Peter Palese
Journal:  Science       Date:  2012-02-23       Impact factor: 47.728

Review 4.  Mammalian-transmissible H5N1 influenza: facts and perspective.

Authors:  Michael T Osterholm; Nicholas S Kelley
Journal:  mBio       Date:  2012-02-24       Impact factor: 7.867
  4 in total
  4 in total

1.  Does exposure to poultry and wild fowl confer immunity to H5N1?

Authors:  Yang Wan; Shaman Jeffrey
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

2.  Virulence attenuation during an influenza A/H5N1 pandemic.

Authors:  Maciej F Boni; Tran Dang Nguyen; Menno D de Jong; H Rogier van Doorn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-04       Impact factor: 6.237

3.  Risks and benefits of gain-of-function experiments with pathogens of pandemic potential, such as influenza virus: a call for a science-based discussion.

Authors:  Arturo Casadevall; Michael J Imperiale
Journal:  MBio       Date:  2014-08-01       Impact factor: 7.867

Review 4.  Surveillance strategy for early detection of unusual infectious disease events.

Authors:  Marion Koopmans
Journal:  Curr Opin Virol       Date:  2013-04-21       Impact factor: 7.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.